Formaldehyde has been classifi ed as carcinogenic to humans (WHO IARC group 1). It causes leukaemia and nasopharyngeal cancer, and was described to regularly occur in alcoholic beverages. However, its risk associated with consumption of alcohol has not been systematically studied, so this study will provide the fi rst risk assessment of formaldehyde for consumers of alcoholic beverages. Human dietary intake of formaldehyde via alcoholic beverages in the European Union was estimated based on WHO alcohol consumption data and literature on formaldehyde contents of different beverage groups (beer, wine, spirits, and unrecorded alcohol). The risk assessment was conducted using the margin of exposure (MOE) approach with benchmark doses (BMD) for 10 % effect obtained from dose-response modelling of animal experiments. For tumours in male rats, a BMD of 30 mg kg -1 body weight per day and a "BMD lower confi dence limit" (BMDL) of 23 mg kg -1 d -1 were calculated from available long-term animal experiments. The average human exposure to formaldehyde from alcoholic beverages was estimated at 8·10
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Formaldehyde (methanal, CH 2 O, CAS # 50-00-0) is a colourless substance, which is widely present in foods, industry, and in the environment (1, 2) and may also be endogenously produced in humans and animals (3) . The industrial use includes mainly the production of various types of resin, the use as intermediate in the manufacture of industrial chemicals, and the direct use in aqueous solutions (formalin) as a disinfectant and preservative (1) (2) (3) . Epidemiological studies have demonstrated a causal relationship between formaldehyde and cancer in humans (3) . Causality is indicated by consistent fi ndings of increased risks of nasopharyngeal cancer, sinonasal cancer, and myeloid leukaemia among individuals with high exposure to formaldehyde. The fi ndings are based on case-control studies of industrial workers and other professional groups in inhalatory contact with formaldehyde such as pathologists, funeral directors or embalmers (3) . Biological mechanisms associated with formaldehydeinduced cancer are not completely understood, but potential carcinogenic modes of actions for formaldehyde include DNA reactivity (covalent binding), gene mutation, chromosomal breakage, aneuploidy, and epigenetic effects (3) . However, the biological plausibility of an association between formaldehyde exposure and leukaemia was questioned, because formaldehyde is rapidly metabolised, and it would not be expected to enter the systemic circulation (3) . No studies in humans are available for the oral route of exposure, but animal feeding experiments have demonstrated that formaldehyde may also be carcinogenic after ingestion (4, 5) .
The hazard of formaldehyde has been confi rmed by the International Agency for Research on Cancer (IARC), which found sufficient evidence for the carcinogenicity of formaldehyde both for humans and experimental animals. The IARC cancer classifi cation was upgraded in 2006 and formaldehyde was assigned to group 1 ("carcinogenic to humans") with clear evidence for cancer in humans (5, 6) .
Formaldehyde is a natural constituent in a variety of fruits, vegetables, meat, milk products, and fi sh (1). Feron et al. (1) (9) . In our on-going investigation of the composition and global public health impact of alcoholic beverages, including unrecorded alcohol (10), we have also detected high formaldehyde concentrations in a number of products (11) . Thus, the natural occurrence of formaldehyde from methanol oxidation in alcohol products, together with contamination from other sources (e.g. the usage of formaldehyde-containing or formaldehydereleasing disinfectants), could therefore be a potential problem on a worldwide scale.
In contrast to other constituents of alcoholic beverages (e.g. methanol, higher alcohols, acetaldehyde or ethyl carbamate), for which excellent risk assessments are available in the literature (12-15), we found a major knowledge gap regarding information about the potential public health impact of formaldehyde, resulting in an inability to adequately ascertain the risk for consumers of the alcoholic beverages researched. In this study, applying the harmonised approach of the European Food Safety Authority (EFSA) (16), we present for the fi rst time, a quantitative risk assessment for formaldehyde in alcoholic beverages.
METHODS
Data on formaldehyde were obtained by a computer-assisted literature search. Searches were carried out in the following databases: PubMed, Toxnet, and ChemIDplus (US National Library of Medicine, Bethesda, MD), Web of Science (Thomson Scientifi c, Philadelphia, PA), and IPCS/INCHEM (International Programme on Chemical Safety/ Chemical Safety Information from Intergovernmental Organizations, WHO, Geneva, Switzerland). We specifi cally aimed to identify long-term animal studies that would be usable for dose-response modelling as well as studies on the occurrence of formaldehyde in alcoholic beverages.
Analysis was conducted according to the harmonised approach of EFSA (16) and similar to our previous acetaldehyde cancer risk assessment (14) . This includes an approach known as the margin of exposure (MOE). MOE is defi ned as the ratio between the benchmark dose (BMD) and the estimated human intake of the same compound. MOE can be used to compare the health risk of different compounds and prioritise risk management actions. By defi nition, the lower the MOE, the larger the risk for humans; generally a value under 10,000 is used to defi ne public health risks (16) . The benchmark dose (BMD), derived from animal data by mathematical modelling within the observed range of experimental data, was used as a reference point. To obtain MOE, the Benchmark Dose Lower Confi dence Limit (BMDL) for a 10 % effect was taken (MOE = BMDL / Exposure). BMDL is an estimate of the lowest dose that is 95 % certain to cause no more than a 10 % effect (e.g. cancer incidence) in rodents. The BMD and BMDL values were calculated using the US EPA's BMDS 2.2 software (available at the US Environmental Protection Agency website: http://www.epa.gov/ncea/bmds/ index.html).
RESULTS

Toxicity of orally ingested formaldehyde in animal studies
There is adequate evidence for the carcinogenicity of formaldehyde in animal experimental studies (6) .
Several studies have proved that long-term inhalation exposure to formaldehyde causes both benign and malignant nasal tumours in male and female rats (17) (18) (19) . As the focus on the specifi c effects of orally administered formaldehyde is relatively new, there are not many studies on this subject. The following two are considered to be the most signifi cant ones: Soffriti et al. (4) conducted a long-term study of rat groups exposed to formaldehyde that resulted in a carcinogenic effect; Til et al. (20) observed severe damage to the gastric mucosa, renal papillary necrosis, and irregular mucosal thickening in the forestomach and/or glandular stomach in rats given top doses of formaldehyde. These studies are discussed in more detail in the section "dose response analysis".
Besides these two pivotal studies, some further studies were identifi ed. In the paper of Tobe et al. (21), groups of 20 male and 20 female Wistar rats were given formaldehyde in their drinking water at four concentrations (0.50, 0.10, 0.02, and 0) % for 24 months. Various non-neoplastic lesions, erosions, and ulcers were found both in the forestomach and glandular stomach mostly in the 0.50 % group. There were no signifi cant differences in the incidence of any tumours among groups of both sexes. Based on their results, the no observable effect level of formaldehyde was 0.02 % in drinking water (10 mg kg
). Another valuable oral study is that of Takahasi et al. (22) , in which Wistar rats were given formaldehyde during a 32-week period at a single concentration level (0.5 % -about 300 mg kg -1 bw per day). Due to the single dose level and/or limited number of animals, these studies were not included in our dose-responsemodelling. However, it is important to mention that although no tumours were observed, papillomas in the forestomach and non-neoplastic changes in glandular stomach were reported (22) . The fi nding suggests that formaldehyde could exert pre-carcinogenic activity in the rat glandular stomach. Long-term or lifetime studies above certain concentration threshold are necessary for detecting tumours (4).
Dose-response analysis
There is no adequate human study available for a dose-response analysis. From the animal experiments mentioned above, two long-term studies of the oral route of exposure to formaldehyde appear to be suitable for dose-response modelling.
Til et al. (20) examined the oral toxicity of formaldehyde in rats in a two-year drinking-water study at dose levels of (0, 1. Due to the lower number of animal subjects and smaller doses, Til et al. (20) provided only limited applicable evidence for dose-response assessments, especially as carcinogenic effects were not detectable. However, we modelled this study for comparison purposes, as irregular thickenings in the forestomach and glandular stomach, chronic atrophic gastritis, and histopathological changes (papillary epithelial hyperplasia accompanied by hyperkeratosis) could be pre-carcinogenic lesions. A large number of oncological lesions of the intestine and the stomach were detected in the study of Soffritti et al. (4) , especially at the highest doses (which were higher than the ones used in Til et al. (20) ). The study by Soffritti et al. (4) is, therefore, the only study adequately designed to be used for a dose-response assessment of carcinogenic effects of orally administered formaldehyde.
The best-fi tting models for different end-points are listed in Table 1 (4) , signifi cant models were reached for both sexes when the total number of tumour-bearing animals was modelled. An adequate model for hemolymphoreticular neoplasias (females) was also observed (Table 1) . Overall, BMDs and BMDLs of models from both studies (4, 20) are in the same order of magnitude, which is indicative of an overall adequacy of the calculated values, as even between (14) . This is consistent with previous assumptions that the toxicity of aldehydes decreases with chain length (24) .
Exposure assessment
In this study we used the EFSA guidelines (16) , which recommend that risk assessments provide different exposure scenarios (e.g. for entire, or specifi c groups of populations) along with their inherent uncertainties. Other than the mean and median, intakes from highly exposed individuals (due to high consumption of average contaminated foods or to average consumption of highly contaminated foods) should be considered as represented by the 90 in brandies. The highest concentrations were typically detected in spirits from Asia (mean 1.23 mg L -1 ). Annual consumption of different types of alcoholic beverages for the population older than 15 can be easily obtained from the WHO databases. This can be done for most countries around the world. However, as studies about formaldehyde concentrations in alcoholic beverages other than European-style beverages are unavailable (especially the knowledge about Asian beverages is based on only very few analytical results), we decided to limit the whole population dietary intake estimate to the European Union (EU). The formaldehyde exposure due to alcoholic beverage consumption was calculated from Table 2 combined with values of annual per capita consumption of alcoholic beverages in the EU (see Lachenmeier et al. (14) for details on annual consumption of different beverage groups). Table 3 summarises the exposure for different scenarios.
Risk characterisation
The exposure data from Table 3 was used to characterise the risk using the margin of exposure (MOE) calculated from BMDL (Table 4) . MOEs can be used by risk managers for setting priorities; small MOE represents a higher risk and vice versa. In general, an MOE of 10,000 or higher, if based on a BMDL from an animal study, would be considered a low public health concern and subsequently a low priority for risk management actions (16) . In the case of formaldehyde, MOEs were in all scenarios above this 10,000 threshold, demonstrating that, in general, formaldehyde in alcoholic beverages appears not to be a public health concern.
This evaluation is in line with previous risk assessments that have considered only non-cancer end-points. For example, the WHO IPCS (2) has established a tolerable concentration (TC) of 2.6 mg L -1 in ingested products based on the experiments of Til et al. (20) . In this respect, some brandies, rum, and Asian spirits are problematic, as these products can contain formaldehyde concentrations above the threshold of 2.6 mg L -1 (see Table 2 ). However, a 60 kg person would need to daily consume 0.8 L of alcohol at 14.37 mg L -1 (the highest concentration found in alcoholic beverages so far) (11) to exceed the US EPA RfD of 0.2 mg kg -1 d -1 (7), which is extremely unlikely even in this worst-case scenario. None of our population-based exposure estimations exceed the US EPA RfD. 
DISCUSSION
In contrast to the risk assessment of another carcinogenic aldehyde -acetaldehyde -for which a considerably lager database about human carcinogenicity and genetic epidemiology exists (14, 49) , our formaldehyde assessment contains several limitations:
1. The assessment is based on only one oral animal study where formaldehyde showed specific carcinogenic effects on various tissues and organs. Some problems with the modelling of these data existed. In particular, the modelling of the data was complicated, as the background levels were relatively high. In addition, the incidence of certain carcinomas was increased in the treated groups, but the statistical power was insuffi cient to allow the modelling of any specifi c cancer site besides hemolymphoreticular neoplasias in females (see also (14) about discussion of the same problems in dose-response modelling of acetaldehyde). Additionally, there are no other estimates for BMDL and BMD values in the literature. However, as the values obtained for different endpoints corresponded well to each other and also to non-cancer endpoints from another study, we believe that the chosen BMDL value is certainly in the right order of magnitude and could be used for quantitative risk assessment.
2. The second important limitation is the fact that we assumed a uniform distribution of formaldehyde in the whole body. However, the tissues that are in direct contact with an alcoholic beverage are exposed at considerably higher levels than other organs. For example, the risk for gastrointestinal tract cancer could be higher, as stomach and intestine lesions have been reported in the animal experiments (4). On the other hand, some recent research has suggested that formaldehyde might enter the systemic circulation of humans exposed to formaldehyde (3), which would justify the application of this assumption to provide a conservative assessment until the mechanism of action has been fully elucidated.
3. The whole population evaluation may underestimate the risk for heavy drinkers and the risk for drinkers that drink predominantly formaldehyde-rich beverages.
Besides alcoholic beverages, humans could be exposed to formaldehyde from other sources. However, the current data only allow rough estimations. Formaldehyde appears in almost all common foods at (1 to 100) mg kg -1 (1) and adult dietary intake is estimated in the range from (1. ) (2). The endogenous levels in human blood were estimated at about 2 mg L -1 to 3 mg L -1 (6) . However, all of these estimates are comparably old and possibly outdated (due to regulatory changes and inadequate analytical methodologies in older studies). Migration of formaldehyde monomers from tableware was pointed 
CONCLUSIONS
The overall conclusion is that the occurrence of trace levels of formaldehyde in alcoholic beverages does not constitute an additional cancer risk for humans. Our data showed that even in worst-case scenarios, the exposure (0.0018 mg kg -1 d -1 ) is lower than thresholds of toxicity (if a threshold-based mechanism is assumed for this carcinogen, which is still a matter of debate) (54) .
Our calculation has revealed that formaldehyde in alcoholic beverages shows MOEs in a magnitude that is not considered a high priority for regulatory measures. For other compounds of alcoholic beverages, such as acetaldehyde or ethyl carbamate, MOEs have been found in considerably lower ranges (below 1000) according to EFSA and Lachenmeier et al. (14, 15) . The major risk, however, certainly comes from ethanol with a MOE of 1 or even smaller (55) . Ethanol was also identifi ed as the most important carcinogen in alcoholic beverages in a comparative quantitative assessment of 15 carcinogenic compounds (56) . This study fully confirms this finding and suggests prioritising general alcohol policy measures over more specifi c measures such as mitigative efforts to reduce the content of trace contaminants such as formaldehyde.
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Sažetak
GRANICA IZLAGANJA FORMALDEHIDU U ALKOHOLNIM PIĆIMA Formaldehid je kancerogen za ljude te je klasifi ciran u skupinu 1 prema WHO IARC-u. Uzrokuje leukemiju i nazofaringealni karcinom, a navodi se i kao redoviti sastojak alkoholnih pića. Međutim, rizik od izlaganja formaldehidu konzumacijom alkoholnih pića nije sustavno istražen pa će ovo istraživanje pružiti prvu takvu procjenu rizika. Količina formaldehida koju ljudi unose alkoholnim pićima u Europskoj je uniji procijenjena temeljem podataka Svjetske zdravstvene organizacije o konzumaciji alkohola i literature o sadržaju formaldehida u različitim skupinama alkoholnih pića (pivo, vino, jaka alkoholna pića i neregistrirani alkohol). Procjena rizika obavljena je korištenjem pristupa granice izlaganja (eng. margin of exposure, MOE) i graničnih doza (eng. benchmark doses, BMD) za 10 %-tni učinak koji se postiže modeliranjem odnosa doza-odgovor u ispitivanjima provedenima na životinjama. BMD od 30 mg kg -1 tjelesne težine na dan i BMD s nižom granicom pouzdanosti (BMDL) od 23 mg kg -1 d -1 izračunati su za tumore kod mužjaka štakora temeljem raspoloživih dugotrajnih ispitivanja provedenih na životinjama. Prosječno izlaganje ljudi formaldehidu u alkoholnim pićima procijenjeno je na 8·10 -5 mg kg -1 d -1
. U usporedbi s BMDL vrijednošću krajnji MOE je iznosio više od 200.000 u prosječnim situacijama. Čak i u najlošijim situacijama MOE nije nikada bio niži od 10.000, što se smatra graničnom vrijednošću za zdravlje ljudi. Procjena rizika pokazuje da je rizik od nastanka karcinoma uslijed izlaganja formaldehidu iz alkoholnih pića zanemariv te da je prioritet upravljanja rizikom u takvim slučajevima (npr. kako bi se smanjila kontaminacija) vrlo nizak. Najveći rizik proizlazi iz etanola i acetaldehida koji se također nalaze u alkoholnim pićima. 
